Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer’s Disease

Author： Pan Xiaobei   Elliott Christopher T.   McGuinness Bernadette   Passmore Peter   Kehoe Patrick G.   Hölscher Christian   McClean Paula L.   Graham Stewart F.   Green Brian D.  

Publisher： MDPI

E-ISSN： 2218-1989|7|2|28-28

ISSN： 2218-1989

Source： Metabolites, Vol.7, Iss.2, 2017-06, pp. : 28-28

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Melatonin in Alzheimer’s Disease

By Lin Li   Huang Qiong-Xia   Yang Shu-Sheng   Chu Jiang   Wang Jian-Zhi   Tian Qing  

International Journal of Molecular Sciences, Vol. 14, Iss. 7, 2013-07 ,pp. : 14575-14593

MDPI

Access to resources Recommend Favorite

Redox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer’s Disease Mice

By Shen Liming   Chen Youjiao   Yang Aochu   Chen Cheng   Liao Liping   Li Shuiming   Ying Ming   Tian Jing   Liu Qiong   Ni Jiazuan  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 469-469

MDPI

Access to resources Recommend Favorite

Alzheimer’s Disease—A Panorama Glimpse

By Zhao Li Na   Lu Lanyuan   Chew Lock Yue   Mu Yuguang  

International Journal of Molecular Sciences, Vol. 15, Iss. 7, 2014-07 ,pp. : 12631-12650

MDPI

Access to resources Recommend Favorite

The Effects of Endogenous Non-Peptide Molecule Isatin and Hydrogen Peroxide on Proteomic Profiling of Rat Brain Amyloid-β Binding Proteins: Relevance to Alzheimer’s Disease?

By Medvedev Alexei E.   Buneeva Olga A.   Kopylov Arthur T.   Gnedenko Oksana V.   Medvedeva Marina V.   Kozin Sergey A.   Ivanov Alexis S.   Zgoda Victor G.   Makarov Alexander A.  

International Journal of Molecular Sciences, Vol. 16, Iss. 1, 2014-12 ,pp. : 476-495

MDPI

Access to resources Recommend Favorite

Measurement of Neuropsychiatric Symptoms in Clinical Trials Targeting Alzheimer’s Disease and Related Disorders

By David Renaud   Mulin Emmanuel   Mallea Patrick   Robert Philippe H.  

Pharmaceuticals, Vol. 3, Iss. 8, 2010-07 ,pp. : 2387-2397

MDPI

Access to resources Recommend Favorite